- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
European Association for the Study of Diabetes
COVID-19 Pandemic Has Made Diabetes Management More Difficult for US Patients
October 04, 2021
An analysis of survey data from nearly 800 patients with diabetes provides insight into the effects of the pandemic on diabetes management, including increased difficulty in affording diabetes medications and consulting with their diabetes care providers.
ADA and EASD Publish Guidance on Diagnosis, Management of Type 1 Diabetes
October 01, 2021
Published on September 30, the consensus report provides perspective on diagnosis and management of type 1 diabetes, including a diagnosis algorithm and insight on CGM specific to type 1 diabetes, which the writing group noted is lacking from previous guidance.
Metabolically Healthy Obesity Still Carries Increased Risk of Heart Failure, Arrhythmia
September 29, 2021
New data presented at EASD 2021 suggests patients with metabolically healthy obesity were at a 34% greater risk of developing new-onset heart failure and a 33% greater risk of new-onset AF than counterparts of healthy weight and no metabolic abnormalities.
Increased Insulin Resistance Could Signal Stroke Risk in Patients with Diabetes
September 28, 2021
A study from EASD 2021 suggests increased insulin resistance could help predict risk of incident stroke events among adult patients with type 2 diabetes, with results indicating lowest levels of insulin resistance were at a 40% lower risk of stroke compared to those with the highest levels.
Major Weight Loss Could Return Cardiovascular Risk to Normal Levels in Patients with Obesity
September 28, 2021
An analysis of NHANES data presented at EASD 2021 details the effects of returning to a healthy weight among patients with obesity compared to those currently with obesity and those who always maintained a healthy weight.
Use of Alendronate Could Lower Odds of Developing Type 2 Diabetes
September 28, 2021
An analysis of patient data from a national registry in Denmark indicates use of alendronate was associated with reductions in odds of developing type 2 diabetes, with this reduction becoming greater with longer use of the osteoporosis medication.
Cardiovascular Care for Women with Diabetes Lagging Behind Care for Men
September 27, 2021
A posthoc analysis of the REWIND trial is providing insight into the overall standard of care seen with women with diabetes and increased cardiovascular risk compared to their male counterparts with diabetes and increased cardiovascular risk.
David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility
September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics
September 25, 2020
A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.
COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics
September 23, 2020
Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.